Creo Medical Share Discussion Threads

[parob] 09/6/2023 08:30

There's been a long period of consolidation since the last placing so those that wanted to flip have probably done so by now. Really encouraging to see those very large buys yesterday and hopefully that's a new II getting on board as hatfullpfsky mentioned.

[someuwin] 09/6/2023 08:15

And again - not much stock available.

[hatfullofsky] 08/6/2023 17:23

Started building a position here off the Vox interview with Paul Jourdan (Amati Capital) 37:15 min in


With the NICE news, cash levels and rapid adoption (Oldham) and now with what looks like an II buying in I'm more positive and have topped up.

[someuwin] 08/6/2023 16:55

I've started a new CREO thread (less header, better charts) here...

[philly cheesesteak] 08/6/2023 16:03

Yep, definitely picking up commercial momentum. This interview was also really good;



They've moved to a place where the general acceptance is that this technology is probably the future & people who've been shaping the industry for many years are concurring with that view...

Just need an update on the Intuitive collab to really get the shares moving.

[someuwin] 08/6/2023 15:53

...Yes, I think the recent selection for NICE assessment could well mark the turning point here.

[philly cheesesteak] 08/6/2023 15:40

Nice work on the new thread - the header on the old one was ridiculous. I've been watching this for some time as it seemed there was a volume overhang holding it back despite lots of good news. The 4m worth of trades this afternoon have flipped the book & it looks set to move higher - was a £300-400m market cap for most of it's listed life before the last 18 months of destruction took place!

[someuwin] 08/6/2023 14:29

Huge 4m+ trade gone through.

[master investor] 08/6/2023 14:21

Always a good sign when directors pump millions of their own cash into a company.

[someuwin] 08/6/2023 09:06

New thread with volume charts

[parob] 08/6/2023 08:54

I reckon the Directors know this is a buyout target hence why they spent over £2M in shares in the last placing.

[master investor] 08/6/2023 08:37

The devices this company have will not only save lives but save the NHS millions, save time and free up beds in hospitals. The potential here is off the scale. I anticipate CREO being acquired within the next 12 months.

[master investor] 31/5/2023 13:00

Hard to believe where the share price is. Just reflects how poor the markets are at the moment.

[edwardt] 24/5/2023 21:25

I can smell an operational inflection point here...

[master investor] 15/5/2023 14:26

Just need to turn those leads into sales now.

[parob] 15/5/2023 08:24

hugely successful Digestive Disease Week Highlights from the event include: - A 288% year on year increase in sales leads directly from the event (compared with 2022 DDW) - Booth visitors from 28 different countries - A dramatic increase in showcased poster presentations and lectures focusing on the role of Speedboat Inject in endoscopic procedures, with one shortlisted and presented at the primary presentation hall for the final day's round up ASGE plenary session - Premier clinicians from across the globe attending Creo Medical's 'Advancing Energy in Third Space Endoscopy: Exploring New Possibilities' symposium, held in conjunction with DDW, including world famous endoscopy experts Prof Hinori Yamamoto and Prof Naohisa Yahagi from Japan - Exciting developments in progressing and finalising distribution agreements for new territories - Providing many leading physicians with a first glimpse of proto-types and pre-release devices behind closed doors Creo Medical CEO Craig Gulliford said : "DDW is an annual event bringing together the world's leading minds in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery, with this year's the most significant in our history. "From presentations and lectures to interest and accolades, we are now seeing Upper GI gastroenterologists, Lower GI Gastroenterologists, Foregut Surgeons, Colorectal surgeons and a whole host besides demonstrating to their peers what our advanced energy devices are delivering for healthcare providers and their patients. It's a real step change in our presence over previous years." David Woods, Chief Commercial Officer of Creo, added: "It's fantastic to see the significant increase in sales leads, orders and broader interest from every corner of the globe during and following what has been a hugely productive DDW for Creo. "Whilst DDW is one of the largest events in the US GI calendar, it is just one of a number of key exhibitions Creo is attending this Spring including a busy ESGE (European Society of Gastrointestinal Endoscopy Days 2023), which occurred in late April, and several upcoming showcase events in the EMEA and APAC over the coming weeks. At each, live Speedboat Inject case features and hands-on experiences are shown, supported by renowned clinicians in the field , underlining how the momentum and adoption of Creo's medtech is growing apace."

[nimbo10] 03/5/2023 12:07

Trading update due for 1st Q 23 sometime this month. As noted in Edison research note.

[parob] 03/5/2023 10:59

Topped up. Hopefully go on a run from here following that slow drip down.

[master investor] 26/4/2023 12:43

We may have to suffer a little longer by the looks of things. The market isn't overly impressed with this set of results.